ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,911Medicare Part D Prescriptions Filled, Including Refills

Rank: 335 out of 1692

$372K Total Retail Price of All Prescriptions

Rank: 443 out of 1692

618 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 618 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 618 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 5,195 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
OMEPRAZOLE 345 253 1 5
HYDROCODONE-ACETAMINOPHEN 305 163 S3 2 6
FUROSEMIDE 286 231 3 7
AMLODIPINE BESYLATE 222 175 4 3
LEVOTHYROXINE SODIUM 210 127 5 4
LISINOPRIL 180 145 6 2
METFORMIN HCL 178 127 7 8
CARVEDILOL 163 138 8 24
HYDROCHLOROTHIAZIDE 146 109 9 9
LOSARTAN POTASSIUM 142 107 10 17
GABAPENTIN 128 89 11 13
SIMVASTATIN 127 90 12 1
ATENOLOL 124 83 13 15
RANITIDINE HCL 113 73 14 28
SERTRALINE HCL 109 81 15 22
NEXIUM 106 42 16 25
TAMSULOSIN HCL 104 89 17 31
WARFARIN SODIUM 104 97 17 14
PRAVASTATIN SODIUM 96 79 19 12
ALLOPURINOL 92 51 20 30
CITALOPRAM HBR 90 46 21 21
ENALAPRIL MALEATE 89 54 22 71
POTASSIUM CHLORIDE 85 61 23 20
TRAMADOL HCL 82 51 24 16
PROAIR HFA 80 32 25 40
METOPROLOL TARTRATE 77 75 26 10
LEVOFLOXACIN 77 52 26 113
TRAZODONE HCL 77 55 26 33
FINASTERIDE 68 63 29 99
FLUOXETINE HCL 63 20 30 52
CHLORTHALIDONE 63 28 30 143
METOPROLOL SUCCINATE 61 57 32 18
TRIAMCINOLONE ACETONIDE 56 38 33 105
ALENDRONATE SODIUM 56 41 33 36
ZOLPIDEM TARTRATE 53 33 35 23
KLOR-CON M20 52 27 36 48
DIGOXIN 50 38 37 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 31 37 19
GEMFIBROZIL 50 40 37 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.